2 Berkeley Street, Suite 403, Toronto, Ontario M5A 2W3 Visit us at: Tel: Fax:
|
|
- Douglas Wells
- 5 years ago
- Views:
Transcription
1 E-Path A.I. Engine Knowledge Base Enhancements Version April 1, 2018 The major enhancements in the E-Path Knowledge Base from versions through are as follows: 1. Addition/modification of ICD-0-3 morphology and topography terms. Morphology New codes: M Midline carcinoma of children and young adults with NUT rearrangement M NUT carcinoma M NUT midline carcinoma M Condylomatous carcinoma M Warty carcinoma (C60.0-C60.2, C60.9) M Squamous cell carcinoma, HPV-positive M Squamous cell carcinoma, HPV-negative M ACTH-producing tumor M Endocrine tumor, functioning, NOS M Adenocarcinoma, pancreatobiliary-type M Pancreatobiliary-type carcinoma M Minimally invasive adenocarcinoma, non-mucinous M Minimally invasive adenocarcinoma, mucinous M Micropapillary carcinoma, NOS M Micropapillary adenocarcinoma M Follicular thyroid carcinoma (FTC), encapsulated angoinvasive M Seromucinous carcinoma M Low grade appendiceal mucinous neoplasm M Solid papillary carcinoma in situ M Solid papillary carcinoma with invasion M Pleomorphic lobular carcinoma in situ M Mixed acinar ductal carcinoma M Mixed germ cell sex cord-stromal tumor, unclassified M Malignant perivascular epithelial cell tumor M PEComa, malignant M Perivascular epithelioid cell tumor, malignant M Solitary fibrous tumor/hemangiopericytoma Grade 2 (CNS) M Calcifying nested epithelial stromal tumor M Biphenotypic sinonasal sarcoma M Germ cell tumors with associated hematological malignancy M Intimal sarcoma M Pulmonary artery intimal sarcoma M Diffuse midline glioma, H3 K27M-mutant Copyright 2018 Artificial Intelligence In Medicine Inc. Page 1 of 5
2 M Papillary tumor of pineal region M Ependymoma, RELA fusion-positive M Pilomyxoid astrocytoma M Angiocentric glioma M Pituicytoma M Glioblastoma, IDH-mutant M Medulloblastoma, WNT-activated M Medulloblastoma, SHH-activated and TP53 mutant M Medulloblastoma, group 3 M Medulloblastoma, group 4 M Medulloblastoma, non-wnt/non-shh M Embryonal tumor with multilayered rosettes C19MC-altered M Embryonal tumor with multilayered rosettes, NOS M Diffuse leptomeningeal glioneuronal tumor M Papillary glioneuronal tumor M Rosette-forming glioneuronal tumor M Epithelioid malignant peripheral nerve sheath tumor M Indolent systemic mastocytosis M Urachal carcinoma M Combined large cell neuroendocrine carcinoma M High-grade neuroendocrine carcinoma M Neuroendocrine carcinoma, poorly differentiated M Small cell carcinoma pulmonary type M Small cell carcinoma, hypercalcemic type M Lipid-rich urothelial carcinoma M Microcystic urothelial carcinoma M Nested urothelial carcinoma M Squamotransitional cell carcinoma M Urothelial carcinoma with divergent differentiation M Urothelial carcinoma with squamous differentiation M Urothelial carcinoma with trophoblastic differentiation M Clear cell (glycogen-rich) urothelial carcinoma M Minimally invasive adenocarcinoma, NOS M Endocervical adenocarcinoma usual type M Enteric adenocarcinoma M Intestinal-type adenocarcinoma M Mucinous carcinoma, intestinal type M Thymic carcinoma with adenoid cystic carcinoma-like features M Serrated adenocarcinoma M Neuroendocrine tumor, well differentiated M Adenocarcinoma in situ, non-mucinous M Lepidic adenocarcinoma Copyright 2018 Artificial Intelligence In Medicine Inc. Page 2 of 5
3 M Lepidic predominant adenocarcinoma M Mixed invasive mucinous and non-mucinous adenocarcinoma M Endometrioid adenocarcinoma, villoglandular M Villoglandular carcinoma M Hereditary leiomyomatosis & RCC- associated renal cell carcinoma M MiT family translocation renal cell carcinoma M Renal cell carcinoma, unclassified M Acquired cystic disease-associated renal cell carcinoma M Tubulocystic renal cell carcinoma M Non-invasive EFVPTC M Non-invasive encapsulated follicular variant of papillary thyroid carcinoma M Non-invasive follicular thyroid neoplasm with papillary-like nuclear features M Non-invasive FTP M Encapsulated follicular variant of papillary thyroid carcinoma, NOS M Invasive encapsulated follicular variant of papillary thyroid carcinoma M Serous endometrial intraepithelial carcinoma M Serous tubal intraepithelial carcinoma M Intraductal papillary mucinous neoplasm with high-grade dysplasia M Intraductal papillary mucinous neoplasm (IPMN) with an associated invasive carcinoma M Non-invasive low grade serous carcinoma M Serous borderline tumor-micropapillary variant M Low-grade serous carcinoma M High-grade serous carcinoma M Mucinous cystic tumor with associated invasive carcinoma M Mucinous tubular and spindle cell carcinoma M Mucinous carcinoma, gastric type M Low grade cribriform cystadenocarcinoma M Mammary carcinoma, in situ M Non-invasive mammary carcinoma M Salivary duct carcinoma M Invasive mammary carcinoma M Intraductal papilloma with ductal carcinoma in situ M Intraductal tubulopapillary neoplasm M Intracystic papillary neoplasm with associated invasive carcinoma M Renal medullary carcinoma M Intraductal papilloma with lobular carcinoma in situ M Invasive lobular carcinoma, alveolar type M Invasive lobular carcinoma, solid type M Invasive lobular carcinoma, tubulolobular variant M Pleomorphic lobular carcinoma M Invasive lobular carcinoma M Tubulolobular carcinoma M Acinar cell carcinoma M Endometrioid carcinoma with squamous differentiation M Low grade adenosquamous carcinoma Copyright 2018 Artificial Intelligence In Medicine Inc. Page 3 of 5
4 M Carcinoma with chondroid differentiation M Carcinoma with osseous differentiation M Metaplastic carcinoma with chondroid differentiation M Metaplastic carcinoma with osseous differentiation M Acinar adenocarcinoma, sarcomatoid M Fibromatosis-like metaplastic carcinoma M Adenocarcinoma admixed with neuroendocrine carcinoma M Carcinoma with other types mesenchymal differentiation M Metaplastic carcinoma with other types mesenchymal differentiation M Metaplastic carcinoma of no special type M MIS M MMIS M Meningeal melanoma M Undifferentiated spindle cell sarcoma M Undifferentiated pleomorphic sarcoma M Undifferentiated round cell sarcoma M Undifferentiated epithelioid sarcoma M Undifferentiated uterine sarcoma M Myxoinflammatory fibroblastic sarcoma M Solitary fibrous tumor/hemangiopericytoma Grade 1 M Solitary fibrous tumor/hemangiopericytoma Grade 3 M Low-grade myofibroblastic sarcoma M Myofibroblastic sarcoma M Malignant fibrous histiocytoma (MFH) of bone M Undifferentiated high-grade pleomorphic sarcoma M Fibrosarcomatous dermatofibrosarcoma protuberans M Low-grade fibromyxoid sarcoma M Sclerosing epithelioid fibrosarcoma M Ossifying fibromyxoid tumor, malignant M Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation M Sclerosing rhabdomyosarcoma M Mullerian adenosarcoma M Adenomyoepithelioma with carcinoma M Phosphaturic mesenchymal tumor, malignant M Periductal stromal tumor, low grade M Adenocarcinoma of rete ovarii M Epithelioid hemangioendothelioma M Low-grade central osteosarcoma M Low-grade intramedullary osteosarcoma M Chondrosarcoma grade 2/3 M Ghost cell odontogenic carcinoma M Clear cell odontogenic carcinoma M Anaplastic oligoastrocytoma M Oligoastrocytoma, NOS M Diffuse astrocytoma, IDH-mutant Copyright 2018 Artificial Intelligence In Medicine Inc. Page 4 of 5
5 M Diffuse astrocytoma, IDH-wildtype M Anaplastic astrocytoma, IDH-mutant M Anaplastic astrocytoma, IDH-wildtype M Anaplastic pleomorphic xanthroastrocytoma M Epithelioid glioblastoma M Glioblastoma, IDH wildtype M Oligodendroglioma, IDH-mutant and 1p/19q-codeleted M Anaplastic oligodendroglioma, IDH-mutant and 1p/19q codeleted M Medulloblastoma, classic M Medulloblastoma, SHH-activated and TP53-wildtype M CNS Embryonal tumor with rhabdoid features M Embryonal tumor with rhabdoid features M Melanotic schwannoma Disable concepts: C52.9 colposcopy Colposcopy is a procedure that examines multiple sites such as cervix, vagina as well as uterus. C57.4 Adnexa Adnexa by itself could refer to any appendages, not just uterine, hence disabled. Topography: C02.9 Oral tongue C44.4 Skin vertex C44.4 Scalp vertex C77.3 Deltopectoral lymph node AIM concepts: AIM005.7 High Grade Aim400.5 Tumor Marker p16 AIM400.6 Tumor Marker Ki67 The above custom codes were added for Louisiana Tumor Registry CDC Audit 2. Additional of synonyms and spelling variants to the ICD-O-3 Morphology and Topography library. 3. Improvements to text processing, context modification and negation detection to improve report selection sensitivity and specificity. Copyright 2018 Artificial Intelligence In Medicine Inc. Page 5 of 5
Effective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific
Effective January 1, 2018 codes, behaviors and terms are site specific /N 8551/3 Acinar adenocarcinoma (C34. _) Lung primaries diagnosed prior to 1/1/2018 use code 8550/3 For prostate (all years) see 8140/3
More informationEffective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific
Effective January 1, 2018 codes, behaviors and terms are site specific Status /N 8010/3 Urachal carcinoma (C65.9, C66.9, C67. _, C68._) 8013/3 Combined large cell neuroendocrine carcinoma (C34. _, C37.9)
More information2018 ICD-O-3 Updates in Table Format with Annotation for Reference
Status Histology Description (this may be preferred term or a synonym) Report Comments New term 8010 3 Urachal carcinoma (C65.9, C66.9, C67._, C68._) New term 8013 3 Combined large cell neuroendocrine
More informationSummary NAACCR: What you need to know for 2017 Version 1.1. March ICD-O-3 Histologies. Reportability There are no reportability changes in 2017.
Summary NAACCR: What you need to know for 2017 Version 1.1. March 2017 ICD-O-3 Histologies 2.1 New Terms and Codes Not Yet Implemented ICD-O-3 s and terms effective for 2015 was postponed due to CSv2 software
More informationS2199 S2200. * Speaker's diagnosis 78
98 21 2 14 13:30 * Speaker's diagnosis 78 S2199 Meningioma 48 Papillary meningioma * 30 Angiomatous meningioma 15 Ependymoma 12 Papillary ependymoma 6 Anaplastic ependymoma 2 Cellular ependymoma 1 Hemangioblastoma
More information2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING
2018 SEER Solid Tumor Manual 2018 KCR SPRING TRAINING Eight Groups are Revised for 2018 Head & Neck Colon (includes rectosigmoid and rectum for cases diagnosed 1/1/2018 forward) Lung (2018 Draft not yet
More informationICD-O Morphology code. R=Rare Tier Tumour ICD-O Topography code C30.0, C31
R=Rare Tier Tumour ICD-O Topography code ICD-O Morphology code EPITHELIAL TUMOURS OF NASAL CAVITY AND SINUSES R 2 Squamous cell carcinoma with variants of nasal cavity and sinuses C30.0, C3 C30.0, C3 8000,
More informationAppendix 4: WHO Classification of Tumours of the pancreas 17
S3.01 The WHO histological tumour type must be recorded. CS3.01a The histological type of the tumour should be recorded based on the current WHO classification 17 (refer to Appendices 4-7). Appendix 4:
More information2018 Updates to National Standards
2018 Updates to National Standards 1 F C D S A N N U A L C O N F E R E N C E O R L A N D O, F L O R I D A 7 / 2 6 / 2 0 1 7 S T E V E N P E A C E, C T R ICD-O-3 New Histology Codes ICD-O-3 Behavior Changes
More informationContents Part I Introduction 1 General Description 2 Natural History: Importance of Size, Site, Histopathology
Contents Part I Introduction 1 General Description... 3 1.1 Introduction... 3 1.2 Incidence and Prevalence... 5 1.3 Predisposing and Genetic Factors... 8 References... 16 2 Natural History: Importance
More informationDATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC #
DATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC #2006-01 CATEGORY: CLARIFICATION SUBJECT: RESCINDMENT - DSQC MEMORANDUM 2002-08 Coding Complex Morphologic Diagnoses (revised 8/02) EFFECTIVE: For Cases
More informationCODING TUMOUR MORPHOLOGY. Otto Visser
CODING TUMOUR MORPHOLOGY Otto Visser INTRODUCTION The morphology describes the tissue of the tumour closest to normal tissue Well differentiated tumours are closest to normal Undifferentiated tumours show
More informationincidence rate x 100,000/year
Tier R=rare C=common Cancer Entity European crude and age adjusted incidence by cancer, years of diagnosis 2000 and 2007 Analisys based on 83 population-based cancer registries * applying the European
More informationRare Breast Tumours. 1. Breast Tumours. 1.1 General Results. 1.2 Incidence
Rare Breast Tumours 1. Breast Tumours 1.1 General Results Table 1. Epithelial Tumours of Breast: Incidence, Trends, Survival Flemish Region 2001-2010 Incidence Trend Survival Females EAPC Relative survival
More informationGUIDELINES FOR ICD-O-3 UPDATE IMPLEMENTATION Effective January 1, 2014
North American Association of Central Cancer Registries, Inc. GUIDELINES FOR ICD-O-3 UPDATE IMPLEMENTATION Effective January 1, 2014 Prepared by the NAACCR ICD-O-3 Update Implementation Work Group December
More informationLung Tumor Cases: Common Problems and Helpful Hints
Lung Tumor Cases: Common Problems and Helpful Hints Brandon T. Larsen, MD, PhD Senior Associate Consultant Department of Laboratory Medicine and Pathology Mayo Clinic Arizona Arizona Society of Pathologists
More information* Speaker's diagnosis
* Speaker's diagnosis Creutzfeldt-Jacob disease(cjd) 5 Prion disease( Creutzfeldt-Jakob disease ) 3 Extrapontine myelinolytis 5 Subacute sclerosing panencephalitis (SSPE) 5 Central pontine myelinolysis
More information4/12/2018. MUSC Pathology Symposium Kiawah Island April 18, Jesse K. McKenney, MD
MUSC Pathology Symposium Kiawah Island April 18, 2018 Jesse K. McKenney, MD 1 Urothelial Carcinoma with Alternative Differentiation 2 Urothelial Carcinoma with Alternative Differentiation Recognition as
More informationMethoden / Methods inc. ICCC-3 105
Methoden / Methods inc. ICCC-3 105 Internationale Klassifikation der Krebserkrankungen bei Kindern (ICCC-3) Zuordnung von ICD-O-3-Codes für Morphologie und Topographie zu diagnostischen Kategorien International
More informationS Y M P O S I U M P R O G R A M
Dear colleagues, dear friends We would like to cordially welcome you to the 10 th International Arkadi M. Rywlin International Pathology Slide Seminar in Anatomic Pathology to be held in Split, Croatia.
More informationSupplementary Information
Rise in Glioblastoma Multiforme incidence in England 1995 2015 suggests an adverse environmental or lifestyle factor Alasdair Philips, Denis L Henshaw, Graham Lamburn, Michael J O Carroll Supplementary
More informationVulva Inflammatory Disorders Lichen Planus Fixed Drug Eruption Erythema Multiforme Plasmacytosis Mucosae (Zoon) Lichen Sclerosus Allergic Contact
Vulva Inflammatory Disorders Lichen Planus Fixed Drug Eruption Erythema Multiforme Plasmacytosis Mucosae (Zoon) Lichen Sclerosus Allergic Contact Dermatitis Psoriasis Lichen Simplex Chronicus Foreign Body
More informationAnnual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology
bs_bs_banner doi:10.1111/jog.12596 J. Obstet. Gynaecol. Res. Vol. 41, No. 2: 167 177, February 2015 Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology
More informationPathology Mystery and Surprise
Pathology Mystery and Surprise Tim Smith, MD Director Anatomic Pathology Medical University of South Carolina Disclosures No conflicts to declare Some problem cases Kidney tumor Scalp tumor Bladder tumor
More informationDifferential Diagnosis of Oral Masses. Palatal Lesions
Differential Diagnosis of Oral Masses Palatal Lesions Palatal Masses Periapical Abscess Torus Palatinus Mucocele Lymphoid Hyperplasia Adenomatous Hyperplasia Benign Salivary Neoplasms Malignant Salivary
More informationDonna M. Hansen, CTR Auditor & Training Coordinator California Cancer Registry
Donna M. Hansen, CTR Auditor & Training Coordinator California Cancer Registry April 2015 2015 Data Changes New Data Items Revised Data Items ICD-0-3 Reportability Change New ICDO Terms and Codes SEER
More informationNorth American Association of Central Cancer Registries, Inc. (NAACCR) What You Need to Know for Version 1.1
North American Association of Central Cancer Registries, Inc. (NAACCR) What You Need to Know for 2017 Version 1.1 January 2017 Revised March 2017 Table of Contents 1 Introduction... 3 2 ICD-O-3 Histologies...
More informationMinimally invasive adenocarcinoma. 5mm or less = microinvasion No necrosis No lymphatic or pleural invasion No spread through air-spaces (STAS)
Minimally invasive adenocarcinoma 5mm or less = microinvasion No necrosis No lymphatic or pleural invasion No spread through air-spaces (STAS) 2b lepidic acinar 2c papillary micropapillary solid 2d cribriform
More informationThe European Commission s science and knowledge service. Joint Research Centre
The European Commission s science and knowledge service Joint Research Centre Coding Primary Site and Tumour Morphology JRC-ENCR training course Copenhagen, 25 September 2018 Nadya Dimitrova Outline What
More informationCANCER REGISTRY 2002
2 National Cancer Institute Department of Medical Services Ministry of Public Health Thailand Edited by Pattarawin Attasara, M.D. ISSN 974-7980-57-6 NATIONAL INSTITUTE STAFFS Consultant : Editor : Office
More informationFINALIZED SEER SINQ QUESTIONS
0076 Source 1: WHO Class CNS Tumors pgs: 33 MP/H Rules/Histology--Brain and CNS: What is the histology code for a tumor originating in the cerebellum and extending into the fourth ventricle described as
More informationWhat is New in the 2015 WHO Lung Cancer Classification? Zhaolin Xu, MD, FRCPC, FCAP
What is New in the 2015 WHO Lung Cancer Classification? Zhaolin Xu, MD, FRCPC, FCAP Professor, Dept of Pathology, Dalhousie University, Canada Pulmonary Pathologist and Cytopathologist, QEII HSC Senior
More informationNormal endometrium: A, proliferative. B, secretory.
Normal endometrium: A, proliferative. B, secretory. Nội mạc tử cung Nội mạc tử cung Cyclic changes in endometrium.. Approximate relationship of useful microscopic changes. Arias-Stella reaction in endometrial
More informationFINALIZED SEER SINQ QUESTIONS
0066 Source 1: 2016 SEER Manual pgs: 78 Notes: Primary Site Primary Site/Corpus uteri: Is the primary site C541 (endometrium) or C543 (uterine fundus) when the histology states endometrial adenocarcinoma,
More informationDisclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction
Disclosures An update on ancillary techniques in the diagnosis of soft tissue tumors. I have nothing to disclose. Andrew Horvai, MD, PhD Clinical Professor, Pathology Introduction Ancillary techniques
More informationBMaP-3 Cancer Database. Aggregate Data File
BMaP-3 Cancer Database Aggregate Data File Contents BMaP-3 Cancer Database... 1 Aggregate Data File... 1 Frequency Tables... 2 Institution... 2 Year_First_Contact... 2 Primary_Site... 3 Sex... 3 Race...
More informationGross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of
Tiền liệt tuyến Tiền liệt tuyến Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of solid and microcystic areas.
More informationANNUAL CANCER REGISTRY REPORT-2015
CANCER STATISTICS Distribution of neoplasms ANNUAL CANCER REGISTRY REPORT-2015 Shahid Mahmood, Raqib Faraz, Aneel Yousaf, Hina Asif, Adna Atif, Farhana Badar Of a total of 5,924 new neoplasms diagnosed
More informationCANCER REGISTRY 2004
2 National Cancer Institute Department of Medical Services Ministry of Public Health Thailand Edited by Pattarawin Attasara, M.D. ISSN 974-7980-57-6 NATIONAL INSTITUTE STAFFS Consultant : Editor : Office
More informationOther Sites. Table 2 Continued. MPH Rules 11/8/07. NAACCR Webinar Series 1
MPH s 11/8/07 Other s 1 Table 2 Continued Use this two-page table to select combination histology codes. Compare the terms in the diagnosis to the terms in Columns 1 and 2. If the terms match, code the
More informationSHN-1 Human Digestive Panel Test results
SHN-1 Human Digestive Panel Test results HN-30 tongue HN-24 salivary gland HN-12 larynx HN-28 esophagus HN-29 stomach HN-20 pancreas HN-13 liver HN-14 gall bladder HN-27-1 duodenum HN-27-2 ileum HN-27-3
More informationDisclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction
Disclosures An update on ancillary techniques in the diagnosis of soft tissue tumors. I have nothing to disclose. Andrew Horvai, MD, PhD Clinical Professor, Pathology Introduction Ancillary techniques
More information04/09/2018. Salivary Gland Pathology in the Molecular Era Old Friends, Old Foes, & New Acquaintances
Salivary Gland Pathology in the Molecular Era Old Friends, Old Foes, & New Acquaintances Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology Chair of Pathology and Laboratory
More informationRare cancers are those with an incidence rate 6/100,000
Rare cancers are those with an incidence rate 6/100,000 Layer Tumour Rate x 100,000 Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES 0.44 3,594 2 Squamous cell carcinoma and variants of the
More informationList of Available TMAs in the PRN
TMA RPCI_BrainCa01 RPCI_BrCa03 RPCI_BrCa04 RPCI_BrCa05 RPCI_BrCa0 RPCI_BrCa07 RPCI_BrCa08 RPCI_BrCa15 RPCI_BrCa1 RPCI_BrCa17 RPCI_BrCa18 RPCI_BrCa19 RPCI_BrCa20 RPCI_BrCa21 RPCI_BrCa24 RPCI_BrCa25 RPCI_BrCa2
More informationSurveys and Anatomic Pathology Education Programs
Surveys and Anatomic Pathology Education Programs Performance Improvement Program in Surgical Pathology PIP/PIPW-B 2017 Participant Summary 2017 College of American Pathologists. The College does not permit
More information2007 Multiple Primary and
2007 Multiple Primary and Histology Coding Rules Beyond the Basics Florida Cancer Data System Annual Conference Tampa, FL July 26,2007 Steven Peace, CTR Westat Carol Johnson, CTR NCI SEER Peggy Adamo,
More informationLayer Tumour Rate Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES Squamous cell carcinoma and variants of the Nasal Cavity
Layer Tumour Rate Patients 1 EPITHELIAL TUMOURS OF THE NASAL CAVITY and SINUSES 0.471 3060 2 Squamous cell carcinoma and variants of the Nasal Cavity and Sinuses 0.37 2615 3 Squamous carcinoma 0.24 1708
More informationFINALIZED SEER SINQ S NOVEMBER 2011
: 20110133 Multiple primaries/heme & Lymphoid Neoplasms: A patient was diagnosed 7/31/08 with DLBCL (9680/3) (biopsy left supraclav. node), stage IIIB. Treated with chemo. 10/14/10 biopsy right supraclav.
More informationProtocol for the Examination of Biopsy Specimens From Patients With Invasive Carcinoma of the Breast
Protocol for the Examination of Specimens From Patients With Invasive Carcinoma of the Breast Version: BreastInvasive 1.0.0.0 Protocol Posting Date: February 2019 Accreditation Requirements The use of
More informationSalivary Glands 3/7/2017
Salivary Glands 3/7/2017 Goals and objectives Focus on the entities unique to H&N Common board type facts Information for your future practice Salivary Glands Salivary Glands Major gland. Paratid. Submandibular.
More informationANNUAL CANCER REGISTRY REPORT-2016, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN
ANNUAL CANCER REGISTRY REPORT-2016, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN Shahid Mahmood, Raqib Faraz, Aneel Yousaf, Ain ul Quader, Hina Asif, Adna Atif, Mehwish Waseem,
More informationCURRICULUM FOR THE BREAST PATHOLOGY ROTATION UNIVERSITY OF FLORIDA DEPARTMENT OF PATHOLOGY
CURRICULUM FOR THE BREAST PATHOLOGY ROTATION UNIVERSITY OF FLORIDA DEPARTMENT OF PATHOLOGY JULY, 2003 The following is a conceptual curriculum and set of guidelines for Pathology Residents on the Breast
More informationSurveys and Anatomic Pathology Education Programs
Surveys and Anatomic Pathology Education Programs Performance Improvement Program in Surgical Pathology PIP/PIPW-B 2018 Participant Summary 2018 College of American Pathologists. The College does not permit
More informationBreast - ductal carcinoma CK7 ER PR GATA3 Mammaglobin (50-70%) GCDFP-15 (50-70%) E-cadherin HMWCK CK20 PAX2 ER/PR/HER2 on all newly diagnosed cases
Adrenal cortical carcinoma Inhibin Synap Melan-A Calretinin Vimentin Chromogr CK7 CK20 Breast - ductal carcinoma CK7 ER PR GATA3 Mammaglobin (50-70%) GCDFP-15 (50-70%) E-cadherin HMWCK CK20 PAX2 ER/PR/HER2
More informationDiagnostically Challenging Cases in Gynecologic Pathology
Diagnostically Challenging Cases in Gynecologic Pathology Eric C. Huang, M.D., Ph.D. Department of Pathology and Laboratory Medicine University of California, Davis Medical Center Case 1 Presentation 38
More informationAppendix E SEER Program Coding and Staging Manual DRAFT Reportable Examples
Appendix E1 2018 SEER Program Coding and Staging Manual DRAFT Reportable Examples Malignant # Diagnosis/Condition Notes 1 Atypical fibroxanthoma (superficial malignant fibrous histiocytoma) 2 Positive
More informationICD-O-3 UPDATES - PENDING
ICD-O-3 UPDATES - PENDING FCDS Annual Meeting July 26, 2013 Sunrise, Florida Steven Peace, CTR ICD-O-3 Work Group ICD-O-3 WORK GROUP Name April Fritz, CTR Lynn Ries, MS Lois Dickie, CTR Linda Mulvihill,
More informationICD-O-3 UPDATES - PENDING
ICD-O-3 UPDATES - PENDING FCDS Annual Meeting July 26, 2013 Sunrise, Florida Steven Peace, CTR ICD-O-3 Work Group ICD-O-3 WORK GROUP Name April Fritz, CTR Lynn Ries, MS Lois Dickie, CTR Linda Mulvihill,
More informationNeoplasias Quisticas del Páncreas
SEAP -Aproximación Práctica a la Patología Gastrointestinal- Madrid, 26 de mayo, 2006 Neoplasias Quisticas del Páncreas Gregory Y. Lauwers, M.D. Director, Service Massachusetts General Hospital Harvard
More informationSUPPLEMENTARY INFORMATION
Supplementary Table 1 trials currently open for patients with pheochromocytoma and/or paraganglima (from trials.gov) www.clinicaltrials.gov; Active PPGL trials Status Of Sunitinib In Patients With Recurrent
More informationEndometrial adenocarcinoma icd 10 code
Endometrial adenocarcinoma icd 10 code Gogamz Menu Cancer of the endometrium, adenocarcinoma ;. (mucous membrane that lines the endometrial cavity). ICD - 10 -CM C54.1 is grouped within. ICD-10 -CM Diagnosis
More informationCase year female. Routine Pap smear
Case 1 57 year female Routine Pap smear Diagnosis? 1. Atypical glandular cells of unknown significance (AGUS) 2. Endocervical AIS 3. Endocervical adenocarcinoma 4. Endometrial adenocarcinoma 5. Adenocarcinoma
More informationVULVAR CARCINOMA. Page 1 of 5
VULVAR CARCINOMA EXAMPLE OF A VULVAR CARCINOMA USING PROPOSED TEMPLATE Case: Invasive squamous cell carcinoma arising in D-VIN Tumor in left labia major Left partial vaginectomy and sentinel lymph node
More informationSpindle Cell Lesions Of The Breast. Emad Rakha Professor of Breast Pathology and Consultant Pathologist
Spindle Cell Lesions Of The Breast Emad Rakha Professor of Breast Pathology and Consultant Pathologist * SCLs comprise a wide spectrum of diseases, ranging from reactive processes to aggressive malignant
More informationMolecular Diagnostics of Head and Neck Tumors Justin A. Bishop, M.D. Associate Professor of Pathology The Johns Hopkins University Baltimore, Maryland
Molecular Diagnostics of Head and Neck Tumors Justin A. Bishop, M.D. Associate Professor of Pathology The Johns Hopkins University Baltimore, Maryland Two Main Topics Molecular insights in salivary gland
More informationFrom Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport
From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology Songlin Zhang, MD, PhD LSUHSC-Shreveport I have no Conflict of Interest. FNA on Lymphoproliferative
More informationRecent advances in breast cancers
Recent advances in breast cancers Breast cancer is a hetrogenous disease due to distinct genetic alterations. Similar morphological subtypes show variation in clinical behaviour especially in response
More informationFINALIZED SEER SINQ QUESTIONS
0067 MP/H Rules/Histology--Kidney: What is the correct histology for this diagnosis? See discussion. Procedure: Nephrectomy Laterality: Left Tumor type: SOLID VARIANT RENAL CELL CARCINOMA Nuclear grade:
More informationANNUAL CANCER REGISTRY REPORT-2017, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN
ANNUAL CANCER REGISTRY REPORT-2017, OF THE SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL & RESEARCH CENTER, PAKISTAN Shahid Mahmood, Raqib Faraz, Aneel Yousaf, Ain ul Quader, Hina Asif, Adna Atif, Lubna Nadeem,
More informationThe role of immunohistochemistry in surgical pathology of the uterine corpus and cervix
The role of immunohistochemistry in surgical pathology of the uterine corpus and cervix Prof. Ben Davidson, MD PhD Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
More information57th Annual HSCP Spring Symposium 4/16/2016
An Unusual Malignant Spindle Cell Lesion to Involve the Breast Erinn Downs-Kelly, D.O. Associate Professor of Pathology University of Utah & ARUP Laboratories No disclosures Case 39 y/o female with no
More informationof 20 to 80 and subsequently declines [2].
- - According to the 2014 World Health Organization (WHO) classification and tumor morphology, primary ovarian tumors are subdivided into three categories: epithelial (60%), germ cell (30%), and sex-cord
More informationS2326. Paucicellular myxoid liposarcoma 1 Histiocytic sarcoma 1 Alveolar soft part sarcoma 1 Perivascular epithelioid cell tumor (PEComa) 1
S2325 Encephalitis 21 Encephalitis 4 Cerebritis 1 Meningoencephalitis 4 Acute disseminated encephalomyelitis 2 Acute encephalitis(virus) 1 Herpes simplex encephalitis* 2 Encephalitis, viral infection?
More informationIASLC 2011/WHO 2015 CLASSIFICATION OF LUNG ADENOCARCINOMAS
Serban Negoita Dylan Holt Marsha Dunn IASLC 2011/WHO 2015 CLASSIFICATION OF LUNG ADENOCARCINOMAS DEMOGRAPHIC PATTERNS, TRENDS, AND IMPLICATIONS FOR CANCER SURVEILLANCE Outline Relevance of lung adenocarcinoma
More informationDetailed Table of Contents
Detailed 1 Immunostains: Introduction... 1 Natasha Rekhtman and Justin Bishop General Background... 1 Applications of Immunohistochemistry in Anatomic Pathology... 1 Markers of Differentiation at a Glance...
More informationWHO 2017: New Classification of Head and Neck Tumours
WHO 2017: New Classification of Head and Neck Tumours Ilmo Leivo Department of Pathology University of Turku & Turku University Hospital FINLAND Suomen IAP Aulanko 18.05.2018 WHO 2017 New entities Simplification
More informationUpdates in Urologic Pathology WHO Made Those Changes?! Peyman Tavassoli Pathology Department BC Cancer Agency
Updates in Urologic Pathology WHO Made Those Changes?! Peyman Tavassoli Pathology Department BC Cancer Agency World Health Organization Available in Feb 2016 Frame work for reporting Major contributing
More informationCutaneous Mesenchymal Neoplasms with EWSR1 Rearrangement
Cutaneous Mesenchymal Neoplasms with EWSR1 Rearrangement By Konstantinos Linos MD, FCAP, FASDP Bone, Soft Tissue and Dermatopathology Assistant Professor of Pathology Dartmouth-Hitchcock Medical Center
More informationMody. AIS vs. Invasive Adenocarcinoma of the Cervix
Common Problems in Gynecologic Pathology Michael T. Deavers, M.D. Houston Methodist Hospital, Houston, Texas Common Problems in Gynecologic Pathology Adenocarcinoma in-situ (AIS) of the Cervix vs. Invasive
More informationEnterprise Interest None
Enterprise Interest None What are triple negative breast cancers? A synopsis of their histological patterns Ian Ellis Molecular Medical Sciences, University of Nottingham Department of Histopathology,
More informationGross appearance of peritoneal cysts. They have a thin, translucent wall and contain a clear fluid.
Gross appearance of peritoneal cysts. They have a thin, translucent wall and contain a clear fluid. So-called multicystic benign mesothelioma. A, Gross appearance. So-called multicystic benign mesothelioma.
More informationPancreatic Cytopathology: The Solid Neoplasms
Pancreatic Cytopathology: The Solid Neoplasms Syed Z. Ali, M.D. Professor of Pathology and Radiology Director of Cytopathology The Johns Hopkins Hospital Baltimore, Maryland Pancreatic Cytopathology: Past,
More informationMolecular pathology in soft tissue tumors. Sylvia Höller Pathologie
Molecular pathology in soft tissue tumors Sylvia Höller Pathologie When do we perform molecular testing? Morphology and IHC are not clearly fitting with an entity some translocations are entity specific
More informationSUPPLEMENTARY INFORMATION
VOLUME: 1 ARTICLE NUMBER: 0027 In the format provided by the authors and unedited. Rapid intraoperative histology of unprocessed surgical specimens via fibre-laser-based stimulated Raman scattering microscopy
More informationSlide seminar: Soft tissue and bone pathology
Slide seminar: Soft tissue and bone pathology Unusual tumors of bone and soft tissue or unusual presentations of common ones Gunhild Mechtersheimer Institute of Pathology, Heidelberg/DE (Sylvia Höller,
More informationChapter 4. Histological groups
Chapter 4. Histological groups D.M. Parkin, J. Ferlay, K. Shanmugaratnam, L. Sobin, L. Teppo and S.L. Whelan In this volume, the main axis of classification is provided by the predominantly site-based
More informationLesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node
Lesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node Oil Cyst Mass, Intermediate Concern Microlobulated Margins Obscured Margins Mass, Favoring Malignant Indistinct
More information3/27/2017. Disclosure of Relevant Financial Relationships
Ophthalmic Pathology Evening Specialty Conference USCAP 2017 5 th March, 2017 Mukul K. Divatia, MD Assistant Professor Department of Pathology & Genomic Medicine Weill Cornell Medical College Houston Methodist
More informationBreast pathology. 2nd Department of Pathology Semmelweis University
Breast pathology 2nd Department of Pathology Semmelweis University Breast pathology - Summary - Benign lesions - Acute mastitis - Plasma cell mastitis / duct ectasia - Fat necrosis - Fibrocystic change/
More informationFinancial disclosures
Cutaneous Mesenchymal Neoplasms with EWSR1 Rearrangement By Konstantinos Linos MD, FCAP, FASDP Bone, Soft Tissue and Dermatopathology Assistant Professor of Pathology Dartmouth-Hitchc Geisel School of
More informationFrequency of non specific morphology codes (ICD O M) within the National Cancer Data Repository ( ) for cancer in Teenagers and Young Adults
Frequency of non specific morphology codes (ICD O M) within the National Cancer Data Repository (2007 09) for cancer in Teenagers and Young Adults (TYA) CTYA SSCRG Data quality report on the frequency
More information3 cell types in the normal ovary
Ovarian tumors 3 cell types in the normal ovary Surface (coelomic epithelium) the origin of the great majority of ovarian tumors 90% of malignant ovarian tumors Totipotent germ cells Sex cord-stromal cells
More informationLudvik R. Donner, MD, PhD Reference List
Gopal S, Marcussen S, Dobin SM, Koss W, Donner LR. Primary myeloid sarcoma of the testicle with t(15;17). Cancer Genetics and Cytogenetics; 157[2]:148-150. 2005 Donner LR, Marcussen S, Dobin SM. A clonal
More informationINDEX. in this web service Cambridge University Press
abscess. See also subareolar abscess acute mastitis, 44 lactational/puerperal mastitis, 55 mammary tuberculosis, 42 tuberculous, 43 adeno gastric, 198, 200 invasive, 157 lung, 197, 200 prostatic, 199 200
More informationIcd 10 code metastatic adenocarcinoma endometrial
Icd 10 code metastatic adenocarcinoma endometrial 1-10-2017 Free, official coding info for 2018 ICD-10-CM D07.0 - includes detailed rules, notes, synonyms, ICD-9-CM conversion,. 2018 ICD-10-CM Diagnosis
More informationQuiz The main functions of the ovaries are a. To produce oocytes b. To produce estrogen c. To produce progesterone d.
1. The main functions of the ovaries are a. To produce oocytes b. To produce estrogen c. To produce progesterone d. All of the above Quiz 1 2. Which part of the broad ligament suspends the ovaries? a.
More informationThe Completeness of Soft Tissue Sarcoma Data in the National Cancer Data Repository
The Completeness of Soft Tissue Sarcoma Data in the National Cancer Data Repository Tumours diagnosed between 2006 and 2008 West Midlands Cancer Intelligence Unit Completeness of cancer data 2008 Soft
More informationNeoplasia literally means "new growth.
NEOPLASIA Neoplasia literally means "new growth. A neoplasm, defined as "an abnormal mass of tissue the growth of which exceeds and is uncoordinated with that of the normal tissues and persists in the
More informationPapillary Lesions of the breast
Papillary Lesions of the breast Emad Rakha Professor of Breast Pathology The University of Nottingham Papillary lesions of the breast are a heterogeneous group of disease, which are characterised by neoplastic
More information